Do not just sit there, do something … but do no harm: the worrying aspects of COVID-19 experimental interventions
Author:
Publisher
Springer Science and Business Media LLC
Subject
Critical Care and Intensive Care Medicine
Link
https://link.springer.com/content/pdf/10.1007/s00134-021-06460-9.pdf
Reference15 articles.
1. Kalil AC, Johnson DW, Lisco SJ, Sun J (2017) Early goal-directed therapy for sepsis. Crit Care Med 45:607–614
2. Singer M, Glynne P (2005) Treating critical illness: the importance of first doing no harm. PLoS Med 2:e167
3. Famous KR, Delucchi K, Ware LB, Kangelaris KN, Liu KD, Thompson BT, Calfee CS, Network ARDS (2017) Acute respiratory distress syndrome subphenotypes respond differently to randomized fluid management strategy. Am J Respir Crit Care Med 195:331–338
4. Calfee CS, Delucchi KL, Sinha P, Matthay MA, Hackett J, Shankar-Hari M, McDowell C, Laffey JG, O’Kane CM, McAuley DF, Irish Critical Care Trials Group (2018) Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial. Lancet Respir Med 2018(6):691–698
5. Antcliffe DB, Burnham KL, Al-Beidh F, Santhakumaran S, Brett SJ, Hinds CJ, Ashby D, Knight JC, Gordon AC (2019) Transcriptomic signatures in sepsis and a differential response to steroids. From the VANISH randomized trial. Am J Respir Crit Care Med 199:980–986
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Uncertainty and decision-making in Critical Care: lessons from managing COVID-19 ARDS for the next pandemic;2024-03-06
2. Complement C5a inhibition: a new form of COVID-19 treatment for mechanically ventilated patients?;The Lancet Respiratory Medicine;2022-12
3. From Cytokine Storm to Cytokine Breeze: Did Lessons Learned from Immunopathogenesis Improve Immunomodulatory Treatment of Moderate-to-Severe COVID-19?;Biomedicines;2022-10-18
4. Less Haste, More Speed, More Science: Lessons to be Learned from COVID-19 Studies;American Journal of Respiratory and Critical Care Medicine;2022-06-01
5. Community-based hospitals: New partners for government-sponsored clinical research during public health emergencies;Vaccine;2021-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3